Journal profile · PHARMACOLOGY & PHARMACY
Current Radiopharmaceuticals
ISSN 1874-4710 · eISSN 1874-4729 · Bentham
Current Radiopharmaceuticals: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.53; hybrid open access; median 131 days to acceptance (12 articles, last 24 months); 29 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Radiopharmaceuticals is published by Bentham and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications and Chemical Reactions and Isotopes, together about 50.1% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Radiopharmaceutical Chemistry and ApplicationsMedicine28.4%
- Medical Imaging Techniques and ApplicationsMedicine15.6%
- Chemical Reactions and IsotopesPharmacology, Toxicology and Pharmaceutics6.1%
- Effects of Radiation ExposureMedicine3.5%
- Prostate Cancer Treatment and ResearchMedicine3.4%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology3.4%
- Neuroendocrine Tumor Research AdvancesMedicine3.3%
- Radiomics and Machine Learning in Medical ImagingMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.53LetPub ·
- CiteScore 2026-06
- 3.2LetPub ·
- SJR 2026-06
- 0.39LetPub ·
- SNIP 2026-06
- 0.47LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 217OpenAlex ·
- 2-year mean citedness
- 1.83OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 9.71%LetPub ·
Volume
- Articles per year
- 22LetPub ·
Articles by year OpenAlex count · 699 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 56 | 56 | 7 |
| 2025 | 29 | 18 | 53 |
| 2024 | 35 | 4 | 160 |
| 2023 | 41 | 4 | 246 |
| 2022 | 34 | 3 | 197 |
| 2021 | 41 | 7 | 208 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
131 daysMedian, submission to acceptance · P25–P75 115 days – 170 days
- Acceptance to online
- median 94 days (12 articles)
- Submission to online
- median 256 days
- Sample
- 12 articles with submission and acceptance dates (104 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham
- ISSN
- 1874-4710
- Electronic ISSN
- 1874-4729
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Current Radiopharmaceuticals
What CAS zone is Current Radiopharmaceuticals in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Radiopharmaceuticals is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Radiopharmaceuticals?
The latest impact factor listed by LetPub is 2.53; CiteScore 3.2, h-index 43.
How long does peer review take at Current Radiopharmaceuticals?
Based on the dates recorded on 12 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 131 days (interquartile range 115–170 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Radiopharmaceuticals?
According to LetPub and DOAJ records, Current Radiopharmaceuticals is indexed in SCIE and Scopus.
Is Current Radiopharmaceuticals open access, and what is the APC?
Current Radiopharmaceuticals is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .